TNDM:NASDAQ
Tandem Diabetes Care Inc
$16.50
0.00%
(0.00) 1D
$16.60
arrow_upward
+0.61% (+0.10)bedtimeAfter hours
Closed: Oct 2, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNDM...
Open
$16.66
High
$17.35
Low
$16.27
Mkt. cap
1.15B
Avg. vol.
1.91M
Volume
2.19M
52-wk high
$29.65
52-wk low
$12.26
EPS
-$0.93
Beta
1.66
Shares outstanding
69.58M
No. of employees
2K
Open
$16.66
High
$17.35
Low
$16.27
Mkt. cap
1.15B
Avg. vol.
1.91M
Volume
2.19M
52-wk high
$29.65
52-wk low
$12.26
EPS
-$0.93
Beta
1.66
Shares outstanding
69.58M
No. of employees
2K
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
History Says Coca-Cola Stock Holds Up When the S&P 500 Falls
U.S. Global Investors
·
1 day ago
Gold Stumbled in September, but Gold Miners Beat Every Sector in the S&P 500
TradingView
·
6 hours ago
Energy sector outperforms S&P 500 in Q3 as oil prices rise
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
About Tandem Diabetes Care Inc
CEOJohn Sheridan
Employees2.5K
FoundedJan 2006
Headquarters-
SectorMedical device
Websitetandemdiabetes.com